Jack A. Khattar

President, CEO

Jack A. Khattar (President, CEO) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in SUPN. The largest single filing was $3.0M of SUPN (58,371 sh × $50.55, as filed), executed Oct 9 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$7.1M

shares × price, as filed

Last traded

Mar 13

Filed Mar 16

Open performance→

Volume by month

Buys $0 Sells $29.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 7 filings

Sector per market data · by filing · past 12 months

Most traded names

SUPN SUPN SUPN · 0 buys · 13 sells 13 filings

Recent filings

SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $2.6M
55,578 sh × $46.01
Exec Sep 5 2025
Filed Sep 8 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $1.6M
34,800 sh across 2 lots
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $5.9M
140,000 sh across 3 lots
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $4.5M
125,000 sh × $36.29
Exec Nov 8 2024
Filed Nov 12 2024 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $4.6M
125,000 sh × $36.68
Exec Nov 7 2024
Filed Nov 8 2024 · 5:30 PM ET